Business ❯ Corporate Governance ❯ Public Companies

Securities Regulation

SEC Filings Investor Relations ImmunityBio, Inc. Digital Assets Investor Compensation Investor Protection Prospectus Requirements Disclosure Obligations

Lufax Investors Urged to Seek Lead Role in Securities Suit Before May 20 Deadline

The rush signals the high stakes of who will direct the lawsuit.

ImmunityBio Faces Investor Suits After FDA Rebuke as Anktiva Sales Jump

Enphase Investors Face April 20 Deadline to Seek Lead Role in Securities Lawsuit

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Aptera Closes $9 Million Public Offering of Stock and Warrants

EquipmentShare Soars 33% in Nasdaq Debut After $747 Million IPO

SharpLink Partners With Superstate to Tokenize SEC-Registered SBET Stock on Ethereum

Red Cat Prices $150 Million Stock Offering at $9.60 as Closing Nears